FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

13888211000001100: Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
242581000001117 Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
242591000001115 Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Is pack of Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials false Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Has active ingredient Eptacog alfa false Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Has VMP Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials true Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Has specific active ingredient Eptacog alfa true Inferred relationship Existential restriction modifier
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Has dispensed dose form Powder and solvent for solution for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
NovoSeven 250,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) 1 vial Is a True Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start